CymaBay amends follow-on

CymaBay Therapeutics Inc. (NASDAQ:CBAY) said it now plans to sell 3.5 million shares in a follow-on. If sold at the company's close of $6.03 on Wednesday, before CymaBay announced the amendment, the company would raise $21.1 million. Cowen; Stifel; Roth Capital Partners; and National Securities are underwriters.

In April, CymaBay (formerly Metabolex Inc.) proposed to raise up to $30 million in the offering and said it planned to move its listing to NASDAQ. The company -- which began trading on NASDAQ last month -- became a publicly reporting company via the Form 10 pathway in October and began trading on the OTCQB in January. ...